These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 857309)

  • 21. An affordable multideterminant plasma-derived hepatitis B virus vaccine.
    Prince AM; Vnek J; Brotman B
    IARC Sci Publ; 1984; (63):355-72. PubMed ID: 6085626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preventive vaccination for viral hepatitis].
    Jilg W
    Z Gastroenterol; 1997 Jul; 35(7):585-90. PubMed ID: 9340933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.
    Akbar SM; Furukawa S; Hasebe A; Horiike N; Michitaka K; Onji M
    Int J Mol Med; 2004 Aug; 14(2):295-9. PubMed ID: 15254781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice.
    Wirth S; Guidotti LG; Ando K; Schlicht HJ; Chisari FV
    J Immunol; 1995 Mar; 154(5):2504-15. PubMed ID: 7868916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Passive and active immunization against hepatitis B virus infection: optimal scheduling in healthy young adults.
    Minuk GY; Bohme CE; Bowen TJ
    Clin Invest Med; 1989 Jun; 12(3):175-80. PubMed ID: 2743636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine against hepatitis B in children: prevention of hepatitis in a pediatric hemodialysis unit.
    Nivet H; Drucker J; Dubois F; Goudeau A; Coursaget P; Rolland JC; Grenier B; Maupas P
    Int J Pediatr Nephrol; 1982 Mar; 3(1):25-8. PubMed ID: 7107116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial.
    Mutchnick MG; Appelman HD; Chung HT; Aragona E; Gupta TP; Cummings GD; Waggoner JG; Hoofnagle JH; Shafritz DA
    Hepatology; 1991 Sep; 14(3):409-15. PubMed ID: 1874487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatitis B vaccine trial in healthy adults - an immunogenicity study (author's transl)].
    Zachoval R; Frösner G; Deinhardt F
    MMW Munch Med Wochenschr; 1981 Oct; 123(40):1506-8. PubMed ID: 6795461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of chronic hepatitis B].
    Carreño V; Montaño L; Torres M
    Rev Clin Esp; 1983 Oct; 171(1):73-6. PubMed ID: 6197728
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific immunotherapy proposed for hepatitis B virus infection.
    Vyas GN; Schmid R; Ibrahim AB; Rao KR
    Dev Biol Stand; 1975; 30():350-6. PubMed ID: 1204970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the effectiveness nine years after primary immunization with local produced plasma-derived hepatitis B vaccine].
    Xu H; Zuo H; Zhuang G
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jul; 32(4):205-7. PubMed ID: 10322755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some considerations regarding active immunization with HBsAg.
    Prince AM; Hashimoto N; Neurath AR; Trepo C
    Dev Biol Stand; 1975; 30():368-74. PubMed ID: 1204972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient increase of HBsAg levels following human IFN alpha treatment signalises the patient's response in chronic active hepatitis B.
    Stancek D; Hajnická V; Blaskovicová H; Sudová J; Laktis K; Janota S; Jezek P
    Acta Virol; 1990 Sep; 34(5):457-66. PubMed ID: 1981456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Problem of chronic hepatitis (classification, pathogenesis and treatment].
    Podymova SD
    Klin Med (Mosk); 1991 Jun; 69(6):9-13. PubMed ID: 1774926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevention of viral hepatitis.
    Krugman S
    Ann Clin Res; 1976 Jun; 8(3):216-20. PubMed ID: 63266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of chronic active hepatitis--newer aspects (author's transl)].
    Havemann K
    Immun Infekt; 1975 Aug; 3(4):199-206. PubMed ID: 1184101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of chronic hepatitis.
    Sherlock S
    Ann Acad Med Singap; 1980 Apr; 9(2):185-7. PubMed ID: 6158903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunotherapy and chemotherapy of viral hepatitis].
    Ito K; Onishi S; Okazaki W; Saibara T; Tachibana M; Nakata F; Yosimoto M; Nakata H; Nakazawa Y; Fukuda Y
    Nihon Rinsho; 1981 Oct; 39(10):3310-22. PubMed ID: 6175777
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapy of chronic hepatitis (author's transl)].
    Siede W
    Dtsch Z Verdau Stoffwechselkr; 1979; 39(2):57-69. PubMed ID: 378653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.